- Dornase alfa (Pulmozyme) Price
- Indications for Dornase alfa (Pulmozyme)
- How to use Dornase alfa (Pulmozyme)
- Side effects of Dornase alfa (Pulmozyme)
- Contraindications for Dornase alfa (Pulmozyme)
Dornase alfa is a respiratory inhalant widely used in the treatment of cystic fibrosis, as it reduces the viscosity of the secretion, improving lung function and reducing the number of lung infections.
Dornase alfa is produced by Roche laboratories and can be purchased at pharmacies under the trade name Pulmozyme.
Dornase alfa (Pulmozyme) Price
The price of Dornase alfa (Pulmozyme) is approximately 1000 reais for packs of 6 ampoules with 2.5 mg of Dornase alfa.
Indications for Dornase alfa (Pulmozyme)
Dornase alfa (Pulmozyme) is indicated as a complement for the treatment of cystic fibrosis.
How to use Dornase alfa (Pulmozyme)
How to use Dornase alfa (Pulmozyme) consists of inhaling 2.5 mg, once or twice a day, depending on the doctor's instructions.
Side effects of Dornase alfa (Pulmozyme)
Side effects of Dornase alfa (Pulmozyme) include sore throat, laryngitis, chest pain, voice changes, conjunctivitis, cough, mild and transient rashes.
Contraindications for Dornase alfa (Pulmozyme)
Dornase alfa (Pulmozyme) is contraindicated during pregnancy and breastfeeding.